Highlight
– Associations between 57 plasma metabolites and dementia risk vary significantly by APOE4 genotype and other AD risk variants.
– Cholesteryl esters and sphingomyelins strongly associate with increased dementia risk in APOE4 homozygotes, while glycerides show inverse relationships exclusive to this genotype.
– Mediterranean diet adherence more effectively modulates dementia-related metabolites in APOE4 homozygotes, suggesting opportunities for genotype-targeted prevention.
– Mendelian randomization identified 19 potentially causal metabolite-cognitive outcome relationships, including protective roles of 4-guanidinobutanoate, carotenoids, and N6-carbamoylthreonyladenosine.
Study Background and Disease Burden
Alzheimer’s disease (AD) and related dementias (AD/ADRD) present a significant global health challenge, with rising prevalence due to aging populations. The heterogeneity of AD, particularly influenced by genetic factors such as the apolipoprotein E4 (APOE4) allele, complicates risk stratification and prevention. APOE4 homozygotes exhibit a distinct subtype with higher disease penetrance and unique pathophysiology. Identification of metabolic pathways linked to genetic risk is critical to uncover modifiable risk factors and guide precision nutrition interventions. Despite advances, effective targeted prevention strategies remain limited, underscoring the need to integrate genomics, metabolomics, and lifestyle factors to refine dementia risk prediction and intervention.
Study Design
This prospective cohort study integrated genetic, plasma metabolomic, and dietary data from a large sample of 4,215 women and 1,490 men. Participants were genotyped for APOE status and other AD-related risk variants, including the rs2154481-C allele in the amyloid precursor protein (APP) gene. Plasma metabolite profiling quantified 57 dementia-associated metabolites. Dietary intake was assessed with particular attention to Mediterranean diet adherence, a dietary pattern characterized by high consumption of fruits, vegetables, whole grains, legumes, nuts, and olive oil. The study evaluated genotype-specific metabolite associations with incident dementia risk and cognitive performance across follow-up periods. Mendelian randomization analyses were employed to infer putative causal relationships between metabolites and cognitive outcomes, enhancing biological plausibility. The predictive value of integrating metabolomics with genetic and lifestyle data was also assessed.
Key Findings
The study revealed pronounced genotype-dependent metabolite associations with dementia risk. In APOE4 homozygotes, elevated plasma levels of cholesteryl esters and sphingomyelins correlated significantly with increased dementia risk. These lipid metabolites likely reflect altered lipid transport and membrane composition relevant to amyloid pathology and neurodegeneration in this genotype. Conversely, glycerides showed protective inverse associations specifically in APOE4 homozygotes, indicating distinct metabolic pathways underpinning risk modulation.
Among carriers of the rs2154481-C variant in APP, increased plasma dimethylguanidino-valeric acid was strongly linked to elevated dementia risk, delineating variant-specific metabolic signatures.
Notably, adherence to the Mediterranean diet more effectively modulated dementia-associated plasma metabolites in APOE4 homozygotes. This suggests that lifestyle interventions tailored by genetic background may yield enhanced preventive benefits. The Mediterranean diet appeared to attenuate adverse metabolite profiles, potentially curbing downstream neurodegenerative pathways.
Integration of metabolomic profiles into dementia risk models modestly improved prediction accuracy, particularly during early follow-up periods. This advance complements genetic risk stratification, enabling more nuanced risk assessment.
Mendelian randomization analyses uncovered 19 putative causal relationships between plasma metabolites and cognitive outcomes. Protective metabolites included 4-guanidinobutanoate, carotenoids, and N6-carbamoylthreonyladenosine. These findings provide mechanistic insights and potential therapeutic targets for cognitive preservation.
Expert Commentary
This comprehensive multi-omics analysis highlights the intricate interplay between genetic predisposition and metabolic pathways in dementia risk. The differential metabolite associations by APOE4 genotype reinforce the concept of genetic subtypes with distinct pathophysiological mechanisms. Targeted modulation of lipid metabolism, especially cholesteryl esters and sphingomyelins, may represent a promising avenue for intervention in APOE4 homozygotes.
The enhanced responsiveness of dementia-associated metabolites to Mediterranean diet adherence in high-risk genotypes underscores the potential of precision nutrition. This approach aligns with emerging paradigms advocating personalized lifestyle interventions based on genetic and metabolic profiling.
However, limitations include observational design and potential residual confounding in dietary and metabolomic assessments. Further randomized controlled trials are warranted to validate causality and clinical efficacy of genotype-guided dietary interventions.
Conclusion
This study elucidates genotype-dependent metabolic profiles underlying dementia risk, revealing distinct associations of plasma metabolites with APOE4 and other AD-related variants. Mediterranean diet adherence emerges as a modifiable factor that differentially influences dementia-related metabolites by genotype, supporting tailored prevention strategies. Incorporating metabolomic data enhances risk prediction beyond genetics alone, with implications for early intervention.
Identification of causally implicated metabolites provides novel targets for biomarker development and therapeutic exploration. Collectively, these findings advance precision nutrition frameworks in Alzheimer’s disease prevention and cognitive health preservation.
References
1. Liu, Y., Gu, X., Li, Y. et al. Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function. Nat Med (2025). https://doi.org/10.1038/s41591-025-03891-5
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261(5123):921-923.
3. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006 Jun;59(6):912-21.
4. Kuhlmann I, Andreassen OA, Taber KH. Advances in neuroimaging for investigation of Alzheimer’s disease and related dementias. Psychiatry Clin Neurosci. 2020 Oct;74(10):517-532.
